Skip to content

Clinical trials

Completed Liver Cirrhosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Status: Completed Country / region: United States Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20033
20041
20051
20064
20071
20082
20103
20115
20123
20136
20143
20156
20163
20177
201817
20196
20208
20219
20229
20235
20244
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed117

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Bristol-Myers Squibb4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Conatus Pharmaceuticals Inc.3
Gilead Sciences3
Hunter Holmes Mcguire Veteran Affairs Medical Center3
Massachusetts General Hospital3
Mayo Clinic3
Stanford University3
University of Michigan3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis117
Fibrosis20
Liver Diseases20
Non-alcoholic Fatty Liver Disease19
Fatty Liver13
Hypertension, Portal13
Hepatitis C10
Hepatitis7
Carcinoma, Hepatocellular6
Hepatic Encephalopathy6

Trials

Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.